Articles from Loyal

Atlanta, Georgia, March 19, 2025 (GLOBE NEWSWIRE) -- Loyal, a leading provider of patient engagement solutions, today announced that Rod Nicholls has joined the organization as Chief Growth Officer. In this role, Nicholls will be responsible for driving the growth of Loyal's Care Activation Platform and patient engagement solutions within the health system market, helping provider organizations enhance digital interactions and optimize the patient experience.

Atlanta, Georgia, March 13, 2025 (GLOBE NEWSWIRE) -- Loyal, a leading provider of patient engagement solutions, is pleased to announce the appointment of Nanette Oddo as its new Chief Executive Officer (CEO). With her extensive experience in healthcare technology and digital transformation, Ms. Oddo will guide the company into its next phase of growth following a successful Series B fundraising round in July 2024.

Loyal, a clinical-stage animal health company developing longevity drugs for dogs, announced today that the FDA’s Center for Veterinary Medicine has accepted the Reasonable Expectation of Effectiveness (RXE) section of its conditional approval application for LOY-002. The drug aims to extend the lifespan of senior dogs and maintain their quality of life as they age, building on the company’s previous RXE acceptance for a longevity drug specifically targeting the short lifespan of large breed dogs.

Loyal, a healthcare technology company dedicated to enabling a healthier life for all, today announced its partnership with UChicago Medicine, a not-for-profit academic health system based on the campus of the University of Chicago in Hyde Park. UChicago Medicine will use Loyal’s Directory Listings solution to manage provider and location information with third-party website integration. This solution aims to ensure UChicago Medicine’s digital front door remains updated with current information for patients.

Loyal, a healthcare technology company dedicated to enabling a healthier life for all, today announced its partnership with Samaritan Medical Center, Watertown, New York, a comprehensive nonprofit network of a hospital, clinics, long term care, home health and physicians services in northern New York. The system will leverage Loyal’s Directory Listings solution to manage provider and location information and increase patient engagement and conversion rates.

Loyal (the “Company”), a healthcare technology company focused on digital patient engagement, today announced it has closed on a $33.5M Series B financing. The round included support from existing investors, Concord Health Partners and multiple strategic investors. The financing is expected to provide resources to expand the Company’s customer base and product development, support customer success and accelerate growth.

Loyal, a leading consumer health platform for some of the nation's top health systems and hospitals and a member of Oracle PartnerNetwork (OPN), today announced that Loyal is available on Oracle Healthcare Marketplace and can be integrated with the Oracle Health Electronic Health Record. Oracle Healthcare Marketplace is a centralized repository of healthcare applications offered by Oracle and Oracle partners.

Loyal, a biotech company pioneering longevity drugs for dogs, today announced that it has successfully completed its Series B funding round, securing $45 million in investment. The round was led by Bain Capital Ventures. This brings total funding raised by Loyal to more than $125 million since its founding in 2019 and includes a $12 million credit facility from Bridge Bank, part of Western Alliance Bank.

Loyal, a biotech company pioneering longevity drugs for dogs, announced today that it has dosed the first dog in its STAY study, the pivotal clinical trial for its LOY-002 drug. LOY-002 is being developed by Loyal to extend the healthy lifespan of senior dogs and maintain their quality of life as they age.

Loyal, a biotech company pioneering longevity drugs for dogs, announced today that the Food and Drug Administration (FDA) Center for Veterinary Medicine has approved the Reasonable Expectation of Effectiveness section of Loyal’s conditional approval application for LOY-001, a drug the company is developing to extend the lifespan of large dogs and maintain their quality of life as they age.

Loyal, a healthcare technology company dedicated to enabling a healthier life for all, announced today it has named Lauren Struck as Loyal’s first ever Chief People Officer. As the company continues to grow, Struck will build a strategic People Operations infrastructure that supports positive and effective communication, provides clear pathways for employee growth and professional development, and continues to build upon and strengthen the company culture and employee experience.

Loyal, the preferred digital health platform for improved care utilization by the nation's leading health systems and hospitals, announced today it has named Austin Pauls as Loyal’s first Chief Financial Officer. In this role, Pauls will work cross-functionally to identify and fulfill opportunities for continued growth and operational excellence.

Loyal, the preferred digital health platform for improved care utilization by the nation's leading health systems and hospitals, announced today that Matt Gove has joined the company as Senior Advisor.

Loyal, the preferred digital health platform for the nation's leading health systems and hospitals, today announced a partnership with Ardent Health Services to deploy Loyal’s suite of consumer engagement solutions.

Loyal, the preferred digital health platform for the nation's leading health systems and hospitals, announced today that its healthcare consumer experience platform has been selected as winner of the “Best Patient Registration and Scheduling Solution” award in the 7th annual MedTech Breakthrough Awards. This program is conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global health and medical technology market.

Loyal, a biotech company developing the world’s first drugs intended to extend the healthy lifespan of dogs, announced today that Blake Scholl has joined as an Independent Director. Scholl brings over 20 years of successful startup, technical, and commercial experience to Loyal as the company progresses towards FDA approval and bringing their first dog aging drugs to vets and pet parents.

Loyal, the preferred consumer health platform for the nation's leading health systems and hospitals, today announced an expanded partnership to offer provider data management and physician search services for PeaceHealth, a nonprofit Catholic health system that provides care to more than 2 million patients annually in Washington, Oregon, and Alaska.

Loyal announced today a major expansion to its existing suite of patient experience technology solutions: a new platform that provides every patient with individualized guidance to get connected with the best care, combining consumer insights with healthcare systems’ operational capabilities and workflows.

“How can I help you today?” the next time you are typing with and “chatting” online with a representative of your bank, airline or favorite shoe store, know that you might be conversing with a very helpful chatbot. A chatbot is a computer program that fundamentally simulates human conversations.